source
- China unveils new five-year plan to boost biotech and pharma and compete globallyChina's government released its latest five-year plan aimed at expanding the country's biotech and pharmaceutical sectors. The document outlines a strategy to strengthen research, development and m…
- GSK adds two China cancer-therapy licensing deals, keeping pace with industry partnership surgeBioPharma Dive's new visualization series recapped recent activity, spotlighting GSK's licensing agreements in China and the market response. Since the start of 2025, GSK has signed five deals wit…